Sartorius Stedim Biotech has entered an agreement to acquire UK-based TAP Biosystems Group in a transaction valued at €33 million. The transaction, subject to customary closing conditions, has been unanimously approved by the boards of directors of both companies and is expected to close at the end of 2013.   TAP Biosystems specializes in the design and development of small-scale, multi-parallel fermentation systems for biopharma applications. Its ambr-product family includes a recently launched...